Evidence map›Paper›PMID 34223010›Full record

ArticleJAC-antimicrobial resistance2020

Impact of an antimicrobial stewardship programme on antimicrobial utilization and the prevalence of MDR

Mazen A Sid Ahmed, Hamad Abdel Hadi, Sulieman Abu Jarir, Abdul Latif Al Khal, Muna A Al-Maslamani, Jana Jass, Emad Bashir Ibrahim, Hisham Ziglam

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Prevalence and microbiological and genetic characteristics of multidrug-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2022
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mazen A Sid AhmedMicrobiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Hamad Abdel HadiDepartments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Sulieman Abu JarirDepartments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Abdul Latif Al KhalDepartments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Muna A Al-MaslamaniDepartments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Jana JassThe Life Science Centre-Biology, School of Science and Technology, Örebro University, Örebro, Sweden.
Emad Bashir IbrahimMicrobiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Hisham ZiglamDepartments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-5562-7693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe excessive and inappropriate use of antibiotics is universal across all healthcare facilities. In Qatar there has been a substantial increase in antimicrobial consumption coupled with a significant rise in antimicrobial resistance (AMR). Antimicrobial stewardship programmes (ASPs) have become a standard intervention for effective optimization of antimicrobial prescribing.

methodsA before-after study was conducted in Hamad General Hospital (603 bed acute care hospital): 1 year before implementation of a comprehensive ASP compared with the following 2 years. The ASP included a hospital-wide pre-authorization requirement by infectious diseases physicians for all broad-spectrum antibiotics. Prevalence of MDR

resultsA total of 6501 clinical isolates of

conclusionsThe successful implementation of the ASP led to a significant reduction in rates of MDR

Identifiers

PMID34223010
PMCPMC8210253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.